Skip to content

MiMedx Group MDXG Free cash flow yield

Free cash flow yield at other companies

IAR
Integra LifeSciencesIART
2.6%-2.1pp
Artivion logo
ArtivionAORT
-0%-1.1pp
Solventum logo
SolventumSOLV
2.9%
Vericel logo
VericelVCEL
2.9%
Enovis logo
EnovisENOV
-2.4%-0.4pp
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
6.6%-5.5pp

Other financials

Income statement

See full
Revenue$59.0M-33.1%
Gross profit$41.6M-41.9%
Operating income-$16.0M-295%
Net income-$10.9M-255%
EPS (diluted)-$0.07-240%

Balance sheet

See full
Cash & equivalents$159.8M+50.1%
Total debt$17.6M-5.7%
Total equity$242.9M+19.8%
Total assets$308.7M+14.1%

Cash flow

See full
Operating cash flow$1.9M-64.5%
CapEx$570.0K+51.2%
Free cash flow$1.3M-73.4%

Valuation

See full
Market cap$567.48M-33.9%
Enterprise value$425.3M-44.8%
P/E18.5×-2.9×
P/S1.5×-1.0×

Profitability

See full
Gross margin81%-0.9pp
Operating margin10.2%-5.1pp
Net margin7.9%-3.5pp
FCF margin17.8%-0.5pp

Returns & leverage

See full
Return on equity13.8%-8.6pp
Debt / equity0.1×0.0×
Current ratio5.4×+0.7×

Where this comes from

Calculated from MiMedx Group’s reported figures.

Based on trailing twelve months.

The official record: MiMedx Group’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiMedx Group's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MiMedx Group's free cash flow yield?
MiMedx Group (MDXG) reported free cash flow yield of 11.8% in Q1 2026.
How has MiMedx Group's free cash flow yield changed year-over-year?
MiMedx Group's free cash flow yield increased by 104.9% year-over-year, from 5.8% to 11.8%.
What is the long-term trend for MiMedx Group's free cash flow yield?
Over 4 years (2020 to 2025), MiMedx Group's free cash flow yield has grown at a 21.1% compound annual growth rate (CAGR), from -3.4% to 7.3%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.